Investigating skin injury caused by chemical agents at the cellular level
The Initiation of Vesicant Skin Injury at a Single Cell Level
This study is exploring how certain harmful chemicals can hurt the skin and cause blisters, and it’s testing a possible treatment to help heal those injuries faster, which could be helpful for anyone affected by chemical exposure.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11104685 on NIH RePORTER |
What this research studies
This research focuses on understanding how chemical agents like sulfur mustard and arsenicals cause skin injuries, specifically looking at the early effects at the single cell level. By examining the role of oxidative stress in these injuries, the study aims to uncover shared mechanisms that lead to large blisters and slow healing. The researchers will use specific chemical compounds as models to simulate the effects of these agents and test a potential antioxidant treatment, cobinamide, to see if it can mitigate the damage. This approach could lead to new therapeutic strategies for treating injuries caused by chemical warfare.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced skin injuries from chemical exposure or are at risk of such injuries due to occupational or environmental factors.
Not a fit: Patients with skin injuries from non-chemical causes or those who do not have a history of exposure to chemical agents may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for skin injuries caused by chemical agents, enhancing recovery and healing for affected individuals.
How similar studies have performed: Previous research has shown promise in understanding the mechanisms of vesicant injuries, but this specific approach focusing on single cell analysis and antioxidant treatment is relatively novel.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Andersen, Bogi — University of California-Irvine
- Study coordinator: Andersen, Bogi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.